Sanofi
SNYNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $115 | $113 | $113 | $109 |
| - Cash | $7 | $9 | $13 | $10 |
| + Debt | $18 | $18 | $21 | $22 |
| Enterprise Value | $125 | $123 | $121 | $121 |
| Revenue | $44 | $46 | $40 | $39 |
| % Growth | -4.6% | 15.2% | 2.9% | – |
| Gross Profit | $31 | $32 | $32 | $27 |
| % Margin | 70.2% | 69.3% | 78.6% | 68.7% |
| EBITDA | $11 | $11 | $14 | $11 |
| % Margin | 24.9% | 23.8% | 33.5% | 28.7% |
| Net Income | $6 | $5 | $8 | $6 |
| % Margin | 12.6% | 11.6% | 20.8% | 15.9% |
| EPS Diluted | 4.43 | 4.3 | 6.66 | 4.95 |
| % Growth | 3% | -35.4% | 34.5% | – |
| Operating Cash Flow | $9 | $10 | $11 | $11 |
| Capital Expenditures | -$3 | -$2 | -$2 | -$2 |
| Free Cash Flow | $6 | $9 | $8 | $8 |